ATE16567T1 - Intravenoes injektierbares globulin aus immunserum und verfahren zu seiner herstellung. - Google Patents
Intravenoes injektierbares globulin aus immunserum und verfahren zu seiner herstellung.Info
- Publication number
- ATE16567T1 ATE16567T1 AT82107262T AT82107262T ATE16567T1 AT E16567 T1 ATE16567 T1 AT E16567T1 AT 82107262 T AT82107262 T AT 82107262T AT 82107262 T AT82107262 T AT 82107262T AT E16567 T1 ATE16567 T1 AT E16567T1
- Authority
- AT
- Austria
- Prior art keywords
- immune serum
- globulin
- production
- composition
- intravenous injectable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39591—Stabilisation, fragmentation
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/295,916 US4396608A (en) | 1981-08-24 | 1981-08-24 | Intravenously injectable immune serum globulin |
EP82107262A EP0073371B1 (de) | 1981-08-24 | 1982-08-11 | Intravenös injektierbares Globulin aus Immunserum und Verfahren zu seiner Herstellung |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE16567T1 true ATE16567T1 (de) | 1985-12-15 |
Family
ID=23139776
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT82107262T ATE16567T1 (de) | 1981-08-24 | 1982-08-11 | Intravenoes injektierbares globulin aus immunserum und verfahren zu seiner herstellung. |
Country Status (9)
Country | Link |
---|---|
US (1) | US4396608A (de) |
EP (1) | EP0073371B1 (de) |
JP (2) | JPH0694421B2 (de) |
AT (1) | ATE16567T1 (de) |
AU (1) | AU549204B2 (de) |
CA (1) | CA1183084A (de) |
DE (1) | DE3267593D1 (de) |
ES (1) | ES515177A0 (de) |
MX (1) | MX7235E (de) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE66616T1 (de) * | 1982-08-30 | 1991-09-15 | Baxter Int | Verfahren zur herstellung von gamma-globulin enthaltenden zusammensetzungen. |
US4439421A (en) * | 1982-08-30 | 1984-03-27 | Baxter Travenol Laboratories, Inc. | Stabilized gamma globulin concentrate |
WO1984001505A1 (en) * | 1982-10-21 | 1984-04-26 | Minneapolis Med Res | Opsonins in peritoneal dialysis |
DK166763C (da) * | 1983-03-16 | 1993-07-12 | Immuno Ag | Immunoglobulin-g-holdig fraktion |
AT383737B (de) * | 1983-03-16 | 1987-08-10 | Immuno Ag | Verfahren zur verwendung einer immunoglobulin-g enthaltenden fraktion |
US4617379A (en) * | 1983-06-14 | 1986-10-14 | Miles Laboratories, Inc. | High titer cytomegalovirus immune serum globulin |
US4719290A (en) * | 1983-09-02 | 1988-01-12 | Armour Pharmaceutical Corporation | Composition of intravenous immune globulin |
US5161472A (en) * | 1984-03-30 | 1992-11-10 | Handy Barry L | Multi-function draft implement |
US4665159A (en) * | 1985-11-07 | 1987-05-12 | Miles Laboratories, Inc. | High titer varicella-zoster immune globulin for intravenous administration |
US4717564A (en) * | 1985-11-07 | 1988-01-05 | Miles Laboratories, Inc. | High titer varicella-zoster immune globulin for intravenous administration |
US4717766A (en) * | 1986-01-27 | 1988-01-05 | Miles Laboratories, Inc. | Method of preparing high titer anti-respiratory syncytial virus intravenous immune globulin |
US4659563A (en) * | 1986-01-27 | 1987-04-21 | Miles Laboratories, Inc. | High titer anti-respiratory syncytial virus intravenous immune globulin |
US4762714A (en) * | 1986-04-08 | 1988-08-09 | Miles Laboratories, Inc. | Preparation of retrovirus-free immunoglobulins |
US5419906A (en) * | 1986-04-08 | 1995-05-30 | Miles Inc. | Preparation of human immunoglobulin free of hepatitis C |
US5159064A (en) * | 1986-04-08 | 1992-10-27 | Miles Inc. | Preparation of virus-free antibodies |
US4948877A (en) * | 1986-04-08 | 1990-08-14 | Miles Laboratories, Inc. | Preparation of retrovirus-free immunoglobulins |
CA1310267C (en) * | 1986-07-09 | 1992-11-17 | Yutaka Hirao | Process for heat treating chemically unmodified _-globulin |
JPH07103045B2 (ja) * | 1986-07-09 | 1995-11-08 | 株式会社ミドリ十字 | 非化学修飾γ−グロブリンの加熱処理方法 |
JP2547556B2 (ja) * | 1987-02-06 | 1996-10-23 | 株式会社 ミドリ十字 | r−グロブリンの液状製剤 |
EP0417191B1 (de) * | 1988-05-27 | 1993-03-10 | Centocor, Inc. | Formulierung für antikörper enthaltende reagenzien |
DE68908175T2 (de) * | 1988-05-27 | 1994-03-03 | Centocor Inc | Gefriergetrocknete formulierung für antikörperprodukte. |
US5945098A (en) * | 1990-02-01 | 1999-08-31 | Baxter International Inc. | Stable intravenously-administrable immune globulin preparation |
US5847086A (en) * | 1991-06-20 | 1998-12-08 | Centeon L.L.C. | Therapeutic fragments of von Willebrand factor |
DE4125625C2 (de) * | 1991-08-02 | 1999-12-02 | Octapharma Ag Glarus | Verfahren zur Herstellung von virusinaktivierten Immunglobulinlösungen |
US5258177A (en) * | 1991-12-10 | 1993-11-02 | Alpha Therapeutic Corporation | IgA preparation and process of making the same |
US6096216A (en) * | 1994-06-09 | 2000-08-01 | American National Red Cross | Iodinated matrices for disinfecting biological fluids |
US6267958B1 (en) | 1995-07-27 | 2001-07-31 | Genentech, Inc. | Protein formulation |
US6686191B1 (en) * | 1995-09-22 | 2004-02-03 | Bayer Healthcare Llc | Preparation of virally inactivated intravenously injectable immune serum globulin |
AU2243997A (en) * | 1996-01-19 | 1997-08-11 | Eli Lilly And Company | Obesity protein formulations |
WO1997026013A1 (en) * | 1996-01-19 | 1997-07-24 | Eli Lilly And Company | Obesity protein formulations |
TW541179B (en) * | 1997-03-19 | 2003-07-11 | Green Cross Corp | Process for preparing immunoglobulin preparation |
EP0973549A2 (de) * | 1997-04-07 | 2000-01-26 | Cangene Corporation | Intravenöse immunglobulinzusammensetzungen die ein nichtionisches oberfläche-aktives agens enthält mit verbesserten pharmakokinetischen eigenschaften |
US6955917B2 (en) * | 1997-06-20 | 2005-10-18 | Bayer Healthcare Llc | Chromatographic method for high yield purification and viral inactivation of antibodies |
US5886154A (en) | 1997-06-20 | 1999-03-23 | Lebing; Wytold R. | Chromatographic method for high yield purification and viral inactivation of antibodies |
US6106773A (en) * | 1998-09-24 | 2000-08-22 | American National Red Cross | Pathogen inactivating compositions for disinfecting biological fluids |
AU2003211991B2 (en) | 2002-02-14 | 2008-08-21 | Chugai Seiyaku Kabushiki Kaisha | Antibody-containing solution formulations |
US20040022792A1 (en) * | 2002-06-17 | 2004-02-05 | Ralph Klinke | Method of stabilizing proteins at low pH |
US20040033228A1 (en) | 2002-08-16 | 2004-02-19 | Hans-Juergen Krause | Formulation of human antibodies for treating TNF-alpha associated disorders |
EP1532983A1 (de) * | 2003-11-18 | 2005-05-25 | ZLB Bioplasma AG | Immunoglobulinpräparationen mit erhöhter Stabilität |
EP1909831A4 (de) | 2005-06-14 | 2013-02-20 | Amgen Inc | Selbstpuffernde proteinformulierungen |
BRPI0719250A2 (pt) * | 2006-10-12 | 2015-06-16 | Wyeth Corp | Métodos e composições com opalescência reduzida. |
US8883146B2 (en) | 2007-11-30 | 2014-11-11 | Abbvie Inc. | Protein formulations and methods of making same |
TWI532498B (zh) | 2008-03-17 | 2016-05-11 | 巴克斯特保健公司 | 供免疫球蛋白及玻尿酸酶之皮下投藥之用的組合及方法 |
EP2271382B1 (de) | 2008-04-15 | 2013-03-13 | Grifols Therapeutics Inc. | Zweistufige Ultrafiltrierung/Diafiltrierung |
MX2012003282A (es) | 2009-09-17 | 2012-04-30 | Baxter Healthcare Sa | Co-formulacion estable de hialuronidasa e inmunoglobulina, y metodos de su uso. |
US9241897B2 (en) | 2010-02-04 | 2016-01-26 | Csl Behring Ag | Immunoglobulin preparation |
EP2361636A1 (de) | 2010-02-26 | 2011-08-31 | CSL Behring AG | Immunglobulinpräparat und Aufbewahrungssystem für ein Immunglobulinpräparat |
ES2381828B1 (es) | 2012-03-20 | 2012-11-16 | Grifols, S.A. | PROCEDIMIENTO PARA OBTENER UNA COMPOSICION DE IgG MEDIANTE TRATAMIENTO TERMICO |
JP6884858B2 (ja) | 2016-10-21 | 2021-06-09 | アムジエン・インコーポレーテツド | 医薬製剤及びその製造方法 |
MA51747A (fr) * | 2018-02-08 | 2020-12-16 | Amgen Inc | Formulation d'anticorps pharmaceutique à ph faible |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2500076C3 (de) * | 1975-01-02 | 1982-11-18 | SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld | Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen |
CA1064396A (en) * | 1975-02-18 | 1979-10-16 | Myer L. Coval | Fractional precipitation of gamma globulin with polyethylene glycol |
US4124576A (en) * | 1976-12-03 | 1978-11-07 | Coval M L | Method of producing intravenously injectable gamma globulin |
JPS5822085B2 (ja) * | 1977-07-19 | 1983-05-06 | 株式会社ミドリ十字 | 静注用ガンマ・グロブリン製剤 |
US4186192A (en) * | 1978-12-18 | 1980-01-29 | Cutter Laboratories, Inc. | Stabilized immune serum globulin |
US4374763A (en) * | 1979-09-17 | 1983-02-22 | Morishita Pharmaceutical Co., Ltd. | Method for producing gamma-globulin for use in intravenous administration and method for producing a pharmaceutical preparation thereof |
EP0498006A1 (de) * | 1991-02-06 | 1992-08-12 | International Business Machines Corporation | Überlagerungsverfahren für den räumlichen Frequenzbereich und Struktur zur Messung der Übereinstimmung von Mustern |
JPH07238036A (ja) * | 1994-02-28 | 1995-09-12 | Green Cross Corp:The | 静注用グロブリン液状組成物のグロブリン二量体増加抑制方法 |
-
1981
- 1981-08-24 US US06/295,916 patent/US4396608A/en not_active Expired - Lifetime
-
1982
- 1982-04-30 CA CA000402009A patent/CA1183084A/en not_active Expired
- 1982-08-05 MX MX8210226U patent/MX7235E/es unknown
- 1982-08-11 AT AT82107262T patent/ATE16567T1/de not_active IP Right Cessation
- 1982-08-11 EP EP82107262A patent/EP0073371B1/de not_active Expired
- 1982-08-11 DE DE8282107262T patent/DE3267593D1/de not_active Expired
- 1982-08-18 AU AU87265/82A patent/AU549204B2/en not_active Expired
- 1982-08-23 JP JP57144887A patent/JPH0694421B2/ja not_active Expired - Lifetime
- 1982-08-23 ES ES515177A patent/ES515177A0/es active Granted
-
1992
- 1992-07-08 JP JP4203184A patent/JPH0761956B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU549204B2 (en) | 1986-01-16 |
JPH0694421B2 (ja) | 1994-11-24 |
MX7235E (es) | 1988-01-26 |
JPH0761956B2 (ja) | 1995-07-05 |
EP0073371A3 (en) | 1983-09-21 |
JPH05208918A (ja) | 1993-08-20 |
AU8726582A (en) | 1983-03-03 |
EP0073371A2 (de) | 1983-03-09 |
US4396608A (en) | 1983-08-02 |
CA1183084A (en) | 1985-02-26 |
ES8306440A1 (es) | 1983-06-01 |
DE3267593D1 (en) | 1986-01-02 |
JPS5843914A (ja) | 1983-03-14 |
EP0073371B1 (de) | 1985-11-21 |
ES515177A0 (es) | 1983-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE16567T1 (de) | Intravenoes injektierbares globulin aus immunserum und verfahren zu seiner herstellung. | |
ATE74766T1 (de) | Verfahren zur herstellung von antikoerperzusammensetzungen von therapeutischen mitteln mit verlaengerter serumhalbwertzeit. | |
DE3482812D1 (de) | Fraktionen von hyaluronsaeure mit pharmazeutischer aktivitaet, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
DE69031763D1 (de) | Steigerungsverfahren der transmembranförderung von exogenen molekülen | |
ATE15798T1 (de) | Heterozyklische carboxamide, zubereitungen, die solche verbindungen enthalten, verfahren zu ihrer herstellung und methoden zur behandlung damit. | |
ES8103976A1 (es) | Un metodo de producir proteinas de interferon humano de for-ma le | |
ATE53038T1 (de) | Inositoltriphosphat, verfahren zu seiner herstellung und dieses enthaltende zubereitung. | |
ATE22657T1 (de) | Prostaglandin e1, enthaltende emulsion und verfahren zu ihrer herstellung. | |
BG40318A3 (en) | Method for preparing imunoglobuline derivatives of vindezine | |
DE68913251D1 (de) | Verfahren zur Verringerung der Heterogenität von monoklonalen Antikörpern. | |
NO934379D0 (no) | Additiv med sporelementer, samt fremgangsm}te ved fremstilling derav | |
DE3581288D1 (de) | Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen. | |
GB1310372A (en) | Phenoxyethylammonium compounds a process for their manufacture and plant growth-regulating preparations containing them | |
DE68914236D1 (de) | Verfahren zur Herstellung von Natriumhyaluronat durch Gärung. | |
DE68907735D1 (de) | Genfragmente, die die variable region eines anti-hiv-antikoerpers codieren, von diesen exprimierte chimaere anti-hiv-antikoerper und verfahren zu deren herstellung. | |
ES455133A1 (es) | Un procedimiento de preparacion de 17-esteres de 17-alfa-hi-droxi-gestogenos. | |
DE3381805D1 (de) | Verfahren zur herstellung von interferon. | |
SE8404334D0 (sv) | 16-fluoro-16,17-didehydro-prostanoids and process for their preparation | |
ATE43610T1 (de) | Acino-foetale differenzierungsproteine verbunden mit krebs des pankreas, antiserum und monoklonale antikoerper gegen diese proteine und verfahren zu ihrer herstellung. | |
ATA592679A (de) | Verfahren zur herstellung von alpha-aryl-alpha, alpha-di(omega-aminoalkyl)acetamiden mit disubstituierter aminogruppe | |
GB1222810A (en) | Prothrombin complex | |
JPS5799598A (en) | Hapten antigen and its synthetic intermediate | |
ES8303916A1 (es) | "un metodo para preparar el antigeno de superficie de la hepatitis b puro a partir de plasma humano". | |
EP0137138A3 (en) | Preparation process of suspension polyvinylchloride, especially suited for injection moulding | |
ATE33842T1 (de) | Immuninterferon und verfahren zu seiner reinigung. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
EEIH | Change in the person of patent owner | ||
EELA | Cancelled due to lapse of time |